Pelican Acquires Minnesota Thermal Science

Pelican Products Inc. has announced the acquisition of Minnesota Thermal Science (MTS), the provider of temperature-controlled transportation products. Based in Plymouth, Minnesota, MTS will merge with Pelican’s already established BioPharma division.
 “The combined entity will offer customers an even wider range of the most advanced temperature controlled packaging solutions for the safe transport of pharmaceuticals, tissue, biologics, diagnostics, blood, and other healthcare products,” said Lyndon Faulkner, president and CEO of Pelican.
 “The award-winning thermal protection products of MTS will be matched with Pelican’s global capabilities providing a worldwide solution of re-usable transportation and packaging products and services,” added.   
In addition to Pelican BioPharma cases that offer 140+ hours between 2.0 to 8.0C, customers will have access to the full suite of MTS products including the reusable Credo Cube, which protects payload contents at defined temperatures longer than any other passive thermal shipper.
Products also include MTS’s Credo Xtreme full pallet which holds 890 liters and the half pallet which holds 406 liters. Each provide 35 percent more payload space than the closest competitor, the company said in a pressrelease.
In addition to their unique scientific packaging, MTS offers a complete range of services and software to support a reusable temperature controlled packaging solution. 
“Joining forces with Pelican will enable us to aim even higher and provide customers with an unmatched global cold chain solution under one company”, said Tom Anderson, CEO of MTS. “We’re confident that together we’ll deliver products and services to the industry better than any competitive offering.  An accelerated product development program which will significantly enhance the combined company’s solution set and associated cold chain services is already underway.”
Pelican Products, Inc. is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco. 
No votes yet